Stockscreener 앱 받기
4.01
2.04%
0.08
전일 마감가:
$3.93
열려 있는:
$3.91
하루 거래량:
26,426
Relative Volume:
0.36
시가총액:
$31.93M
수익:
$2.74M
순이익/손실:
$-41.38M
주가수익비율:
-0.8514
EPS:
-4.71
순현금흐름:
$-31.10M
1주 성능:
+8.67%
1개월 성능:
+22.63%
6개월 성능:
+48.52%
1년 성능:
+23.77%
1일 변동 폭
$3.8301
$4.12
1주일 범위:
$3.385
$4.12
52주 변동 폭
$1.3701
$4.55
Lumos Pharma Inc Stock (LUMO) Company Profile
명칭
Lumos Pharma Inc
전화
512-215-2630
주소
4200 MARATHON BLVD., AUSTIN, TX
Lumos Pharma Inc Stock (LUMO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-11 | 업그레이드 | Stifel | Hold → Buy |
| 2020-12-03 | 개시 | Cantor Fitzgerald | Buy |
| 2020-08-26 | 개시 | Piper Sandler | Overweight |
| 2020-08-17 | 재개 | ROTH Capital | Buy |
| 2020-08-04 | 개시 | H.C. Wainwright | Buy |
Lumos Pharma Inc 주식(LUMO)의 최신 뉴스
AEON Biopharma (AMEX:AEON) Stock Quotes, Forecast and News Summary - Benzinga
Selling Buzz: Lumos Pharma Inc [LUMO] Chief Scientific Officer McKew John C. sells 3,407 shares of the company - Knox Daily
Taking a look at what insiders are doing to gauge the Aadi Bioscience Inc (AADI)’s direction - Knox Daily
Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024 - StockTitan
Atlantic Union Bankshares Corp [AUB] Records 50-Day SMA of $37.13 - Knox Daily
The growth track for Lumos Pharma Inc (LUMO) has changed recently - SETE News
Lumos Pharma Inc (LUMO) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
A preview of the September Tech issue of Contemporary Pediatrics - Contemporary Pediatrics
Lumos Diagnostics Holdings Full Year 2024 Earnings: US$0.018 loss per share (vs US$0.038 loss in FY 2023) - Yahoo Finance
A company insider recently sold 3,407 shares of Lumos Pharma Inc [LUMO]. Should You also Consider to Sale? - Knox Daily
Lumos Adds Prominent Security Industry Veterans to Board, Leadership Team - Yahoo Finance
Lumos Pharma to Participate in World Orphan Drug Congress USA - GuruFocus.com
Uncovering the Potential of Lumos Pharma Inc (LUMO) Stock - The InvestChronicle
Reviewing Lumos Pharma (NASDAQ:LUMO) & Korro Bio (NASDAQ:KRRO) - Defense World
Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com
Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Brokers Issue Forecasts for Lumos Pharma, Inc.’s FY2024 Earnings (NASDAQ:LUMO) - Defense World
FY2024 EPS Estimates for SIGA Technologies, Inc. Cut by Analyst (NASDAQ:SIGA) - Defense World
MAG Silver Corp. (NYSEAMERICAN:MAG) to Post FY2024 Earnings of $0.79 Per Share, Stifel Canada Forecasts - Defense World
LGI Homes, Inc. (NASDAQ:LGIH) Forecasted to Earn FY2024 Earnings of $9.10 Per Share - Defense World
Lumos Pharma (NASDAQ:LUMO) PT Lowered to $13.00 at Oppenheimer - Defense World
Lumos Pharma Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Lumos Pharma, Inc. (NASDAQ:LUMO) Q2 2024 Earnings Call Transcript - Insider Monkey
Lumos: Q2 Earnings Snapshot - The Washington Post
Lumos: Q2 Earnings Snapshot - San Francisco Chronicle
Lumos Pharma, Inc. (LUMO) Q2 2024 Earnings Call Transcript - Seeking Alpha
Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update - wallstreet:online
Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update - ForexTV.com
Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update - StockTitan
Lumos Pharma (LUMO) to Release Earnings on Thursday - Defense World
True Nature (OTCMKTS:TNTY) Stock Passes Below 200 Day Moving Average of $0.29 - Defense World
BNP Paribas Financial Markets Has $307,000 Holdings in Stitch Fix, Inc. (NASDAQ:SFIX) - Defense World
NBT Bancorp Inc. (NASDAQ:NBTB) Shares Acquired by Russell Investments Group Ltd. - Defense World
Janney Montgomery Scott LLC Grows Holdings in FormFactor, Inc. (NASDAQ:FORM) - Defense World
Marinus Pharmaceuticals (NASDAQ:MRNS) Shares Cross Below 200 Day Moving Average of $5.34 - Defense World
Silvaco Group, Inc. (NASDAQ:SVCO) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Proto Labs, Inc. (NYSE:PRLB) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Passes Below 200 Day Moving Average of $2.58 - Defense World
Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024 - StockTitan
Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024 - ForexTV.com
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Quotes, Forecast and News Summary - Benzinga
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Average Rating of “Buy” by Brokerages - Defense World
Enova International, Inc. (NYSE:ENVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Avino Silver & Gold Mines (NYSE:ASM) Shares Down 7.6% - Defense World
Great-West Lifeco Inc. (TSE:GWO) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
MidWestOne Financial Group (MOFG) Scheduled to Post Earnings on Thursday - Defense World
FirstService (TSE:FSV) Share Price Crosses Above 200-Day Moving Average of $214.46 - Defense World
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Rating of “Buy” from Analysts - Defense World
Lumos Pharma Reports Full Year 2021 Financial Results and Announces Plan to Perform Interim Analyses of OraGrowtH Trials - Barchart
Austin's life sciences sector is booming — can it catch up to other top U.S. hubs? - The Business Journals
Down 16.1% in 4 Weeks, Here's Why Lumos (LUMO) Looks Ripe for a Turnaround - Yahoo New Zealand News
Lumos Pharma Inc (LUMO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lumos Pharma Inc 주식 (LUMO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| McKew John C. | Chief Scientific Officer |
Apr 03 '24 |
Sale |
2.77 |
2,214 |
6,144 |
17,153 |
| McKew John C. | Chief Scientific Officer |
Feb 06 '24 |
Sale |
3.03 |
438 |
1,328 |
18,403 |
1.25%
1.94%
자본화:
|
볼륨(24시간):